168 related articles for article (PubMed ID: 16965772)
1. Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells.
Laengle UW; Markstein R; Pralet D; Seewald W; Roman D
Exp Eye Res; 2006 Dec; 83(6):1335-9. PubMed ID: 16965772
[TBL] [Abstract][Full Text] [Related]
2. Effects of latanoprost, timolol and GLC756, a novel dopamine D(2) agonist and D(1) antagonist on LTC(4) release after rat mast cell activation.
Laengle UW; Markstein R; Pralet D; Seewald W; Roman D
Clin Exp Ophthalmol; 2007; 35(7):645-50. PubMed ID: 17894685
[TBL] [Abstract][Full Text] [Related]
3. Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in rats.
Laengle UW; Markstein R; Schneider V; Greiner B; Roman D
Exp Eye Res; 2005 Jun; 80(6):847-52. PubMed ID: 15939041
[TBL] [Abstract][Full Text] [Related]
4. Effects of antiglaucoma drugs GLC756, a novel dopamine D2 agonist and D1 antagonist, and timolol on endotoxin-induced TNF-alpha release in serum of rats.
Laengle UW; Markstein R; Schneider V; Roman D
Eur J Ophthalmol; 2006; 16(3):401-6. PubMed ID: 16761241
[TBL] [Abstract][Full Text] [Related]
5. Effects of anti-glaucoma drugs timolol and GLC756, a novel mixed dopamine D2 receptor agonist and D1 receptor antagonist, on endotoxin-induced-uveitis and -arthritis in rats.
Laengle UW; Court M; Markstein R; Germann PG; Nogues V; Roman D
Exp Toxicol Pathol; 2005 Nov; 57(2):127-34. PubMed ID: 16325523
[TBL] [Abstract][Full Text] [Related]
6. Effects of latanoprost and GLC756, a novel dopamine D2 agonist and D1 antagonist, on cultured normal human dermal fibroblasts.
Laengle UW; Markstein R; Pralet D; Greiner B; Roman D
Eur J Ophthalmol; 2006; 16(1):67-72. PubMed ID: 16496248
[TBL] [Abstract][Full Text] [Related]
7. Antiglaucoma drug GLC756 and its effect on cellular cAMP and tumor necrosis factor alpha release in vitro of activated human monocytic leukemia cells.
Laengle UW; Markstein R; Cazaubon C; Roman D
Jpn J Ophthalmol; 2009 Mar; 53(2):159-163. PubMed ID: 19333701
[TBL] [Abstract][Full Text] [Related]
8. Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-alpha release, transcription, and degranulation.
Hide I; Toriu N; Nuibe T; Inoue A; Hide M; Yamamoto S; Nakata Y
J Immunol; 1997 Sep; 159(6):2932-40. PubMed ID: 9300717
[TBL] [Abstract][Full Text] [Related]
9. Gene expression and production of tumour necrosis factor by a rat basophilic leukaemia cell line (RBL-2H3) with IgE receptor triggering.
Ohno I; Tanno Y; Yamauchi K; Takishima T
Immunology; 1990 May; 70(1):88-93. PubMed ID: 2141321
[TBL] [Abstract][Full Text] [Related]
10. GLC756 decreases TNF-alpha via an alpha2 and beta2 adrenoceptor related mechanism.
Laengle UW; Trendelenburg AU; Markstein R; Nogues V; Provencher-Bollinger A; Roman D
Exp Eye Res; 2006 Nov; 83(5):1246-51. PubMed ID: 16938291
[TBL] [Abstract][Full Text] [Related]
11. Cholera toxin increases IL-6 synthesis and decreases TNF-alpha production by rat peritoneal mast cells.
Leal-Berumen I; Snider DP; Barajas-Lopez C; Marshall JS
J Immunol; 1996 Jan; 156(1):316-21. PubMed ID: 8598479
[TBL] [Abstract][Full Text] [Related]
12. Effect of natsudaidain isolated from Citrus plants on TNF-alpha and cyclooxygenase-2 expression in RBL-2H3 cells.
Matsui T; Ito C; Itoigawa M; Okada T; Furukawa H
J Pharm Pharmacol; 2009 Jan; 61(1):109-14. PubMed ID: 19126304
[TBL] [Abstract][Full Text] [Related]
13. Target-specific activation of mast cells by immunoglobulin E reactive with a renal cell carcinoma-associated antigen.
Luiten RM; Fleuren GJ; Warnaar SO; Litvinov SV
Lab Invest; 1996 Feb; 74(2):467-75. PubMed ID: 8780164
[TBL] [Abstract][Full Text] [Related]
14. Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells.
Leal-Berumen I; O'Byrne P; Gupta A; Richards CD; Marshall JS
J Immunol; 1995 May; 154(9):4759-67. PubMed ID: 7536779
[TBL] [Abstract][Full Text] [Related]
15. The regulation of tumor necrosis factor-alpha production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanisms.
Schmidt-Choudhury A; Furuta GT; Lavigne JA; Galli SJ; Wershil BK
Cell Immunol; 1996 Jul; 171(1):140-6. PubMed ID: 8660849
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of the release of tumor necrosis factor-alpha and of eicosanoids by mast cells in rat airways after antigen challenge.
Trezena AG; da Silva ZL; Oliveira-Filho RM; Damazo AS; Straus AH; Takahashi HK; Oliani SM; de Lima WT
Mediators Inflamm; 2003 Aug; 12(4):237-46. PubMed ID: 14514475
[TBL] [Abstract][Full Text] [Related]
17. Novel sulfhydryl-reactive compounds orazipone and OR-1958 inhibit cytokine production and histamine release in rat and human mast cells.
Vendelin J; Laitinen C; Vainio PJ; Nissinen E; Mäki T; Eklund KK
Int Immunopharmacol; 2005 Jan; 5(1):177-84. PubMed ID: 15589479
[TBL] [Abstract][Full Text] [Related]
18. Natural cytotoxic cell-specific cytotoxic factor produced by IL-3-dependent basophilic/mast cells. Relationship to TNF.
Richards AL; Okuno T; Takagaki Y; Djeu JY
J Immunol; 1988 Nov; 141(9):3061-6. PubMed ID: 3262677
[TBL] [Abstract][Full Text] [Related]
19. Suppression of mast cell-mediated allergic reaction by Amomum xanthiodes.
Kim SH; Lee S; Kim IK; Kwon TK; Moon JY; Park WH; Shin TY
Food Chem Toxicol; 2007 Nov; 45(11):2138-44. PubMed ID: 17602813
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNF-alpha production by mast cells.
Bissonnette EY; Enciso JA; Befus AD
J Immunol; 1996 Jan; 156(1):218-23. PubMed ID: 8598465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
